Answers are grounded in this paper and cite their sources.
Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease characterized by excessive deposition of extracellular matrix, primarily type I collagen. This study investigates the role of Collagen triple helix repeat containing 1 (CTHRC1) in pulmonary fibrosis. Analysis of public databases and validation in mouse models revealed that CTHRC1 expression is significantly upregulated and strongly correlates with type I collagen. Single-cell RNA sequencing and immunofluorescence supported a close association between CTHRC1 and myofibroblasts in fibrotic lungs. In vitro, CTHRC1 knockdown in NIH3T3 fibroblasts attenuated TGF-β1-induced type I collagen production. Mechanistically, CTHRC1 silencing reduced phosphorylation of the TGF-β receptor I and its downstream effectors Smad2/3, accompanied by reduced protein expression of the transcription factor ATF4 and its target, the collagen synthesis enzyme PSAT1. These findings support a CTHRC1–TGF-β/Smad–ATF4/PSAT1 signaling model for type I collagen regulation, providing a basis for further investigation of CTHRC1 and the associated pathway as potential therapeutic targets in IPF.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: